COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:CBHD - DK0060448595 - Common Stock
75.44 EUR
-2.22 (-2.86%)
We assign a fundamental rating of 5 out of 10 to CBHD. CBHD was compared to 63 industry peers in the Health Care Equipment & Supplies industry. While CBHD has a great profitability rating, there are some minor concerns on its financial health. CBHD has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year CBHD was profitable.
In the past year CBHD had a positive cash flow from operations.
CBHD had positive earnings in each of the past 5 years.
Each year in the past 5 years CBHD had a positive operating cash flow.
1.2 Ratios
CBHD has a better Return On Assets (7.52%) than 80.95% of its industry peers.
With an excellent Return On Equity value of 22.55%, CBHD belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
The Return On Invested Capital of CBHD (12.65%) is better than 92.06% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CBHD is above the industry average of 9.81%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROIC | 12.65% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
1.3 Margins
CBHD's Profit Margin of 13.04% is fine compared to the rest of the industry. CBHD outperforms 76.19% of its industry peers.
CBHD's Profit Margin has declined in the last couple of years.
CBHD has a Operating Margin of 27.52%. This is amongst the best in the industry. CBHD outperforms 95.24% of its industry peers.
CBHD's Operating Margin has declined in the last couple of years.
CBHD has a Gross Margin of 67.97%. This is in the better half of the industry: CBHD outperforms 74.60% of its industry peers.
CBHD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% |
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CBHD is creating value.
The number of shares outstanding for CBHD remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CBHD has more shares outstanding
Compared to 1 year ago, CBHD has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.91 indicates that CBHD is not in any danger for bankruptcy at the moment.
CBHD's Altman-Z score of 3.91 is fine compared to the rest of the industry. CBHD outperforms 68.25% of its industry peers.
CBHD has a debt to FCF ratio of 4.34. This is a neutral value as CBHD would need 4.34 years to pay back of all of its debts.
With a Debt to FCF ratio value of 4.34, CBHD perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
CBHD has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.24, CBHD is doing worse than 84.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Altman-Z | 3.91 |
ROIC/WACC2.23
WACC5.67%
2.3 Liquidity
A Current Ratio of 1.61 indicates that CBHD should not have too much problems paying its short term obligations.
With a Current ratio value of 1.61, CBHD perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
CBHD has a Quick Ratio of 1.00. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
CBHD has a Quick ratio of 1.00. This is comparable to the rest of the industry: CBHD outperforms 42.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The earnings per share for CBHD have decreased strongly by -20.93% in the last year.
The Earnings Per Share has been decreasing by -2.02% on average over the past years.
Looking at the last year, CBHD shows a small growth in Revenue. The Revenue has grown by 3.12% in the last year.
The Revenue has been growing by 8.49% on average over the past years. This is quite good.
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
3.2 Future
The Earnings Per Share is expected to grow by 16.78% on average over the next years. This is quite good.
Based on estimates for the next years, CBHD will show a small growth in Revenue. The Revenue will grow by 7.08% on average per year.
EPS Next Y46.87%
EPS Next 2Y27.18%
EPS Next 3Y21.46%
EPS Next 5Y16.78%
Revenue Next Year5.02%
Revenue Next 2Y6.25%
Revenue Next 3Y6.66%
Revenue Next 5Y7.08%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 31.70, CBHD can be considered very expensive at the moment.
CBHD's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.34, CBHD is valued a bit more expensive.
The Price/Forward Earnings ratio is 21.60, which indicates a rather expensive current valuation of CBHD.
CBHD's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.56. CBHD is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.7 | ||
| Fwd PE | 21.6 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CBHD is valued a bit cheaper than the industry average as 60.32% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CBHD is valued a bit cheaper than 74.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.7 | ||
| EV/EBITDA | 15.36 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBHD has a very decent profitability rating, which may justify a higher PE ratio.
CBHD's earnings are expected to grow with 21.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y27.18%
EPS Next 3Y21.46%
5. Dividend
5.1 Amount
CBHD has a Yearly Dividend Yield of 3.93%. Purely for dividend investing, there may be better candidates out there.
CBHD's Dividend Yield is rather good when compared to the industry average which is at 2.14. CBHD pays more dividend than 96.83% of the companies in the same industry.
CBHD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.93% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
136.36% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
CBHD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP136.36%
EPS Next 2Y27.18%
EPS Next 3Y21.46%
FRA:CBHD (12/8/2025, 7:00:00 PM)
75.44
-2.22 (-2.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners29.27%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap15.86B
Revenue(TTM)27.87B
Net Income(TTM)3.64B
Analysts70
Price Target92.6 (22.75%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.93% |
Yearly Dividend2.95
Dividend Growth(5Y)5.3%
DP136.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25%
Min EPS beat(2)-26.06%
Max EPS beat(2)-23.94%
EPS beat(4)0
Avg EPS beat(4)-20.18%
Min EPS beat(4)-26.06%
Max EPS beat(4)-15.32%
EPS beat(8)0
Avg EPS beat(8)-12.22%
EPS beat(12)0
Avg EPS beat(12)-10.75%
EPS beat(16)1
Avg EPS beat(16)-9.6%
Revenue beat(2)0
Avg Revenue beat(2)-2.46%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-2.12%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.37%
Revenue beat(12)1
Avg Revenue beat(12)-1.51%
Revenue beat(16)4
Avg Revenue beat(16)-0.95%
PT rev (1m)-0.16%
PT rev (3m)-3.58%
EPS NQ rev (1m)7.53%
EPS NQ rev (3m)17.67%
EPS NY rev (1m)0.81%
EPS NY rev (3m)-2.74%
Revenue NQ rev (1m)5.95%
Revenue NQ rev (3m)8.83%
Revenue NY rev (1m)-0.57%
Revenue NY rev (3m)-1.93%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.7 | ||
| Fwd PE | 21.6 | ||
| P/S | 4.25 | ||
| P/FCF | 22.7 | ||
| P/OCF | 17.82 | ||
| P/B | 7.35 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.36 |
EPS(TTM)2.38
EY3.15%
EPS(NY)3.49
Fwd EY4.63%
FCF(TTM)3.32
FCFY4.41%
OCF(TTM)4.23
OCFY5.61%
SpS17.75
BVpS10.27
TBVpS-8.72
PEG (NY)0.68
PEG (5Y)N/A
Graham Number23.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROCE | 18.32% | ||
| ROIC | 12.65% | ||
| ROICexc | 12.94% | ||
| ROICexgc | 47.68% | ||
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% | ||
| FCFM | 18.72% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Debt/EBITDA | 2.2 | ||
| Cap/Depr | 98.21% | ||
| Cap/Sales | 5.12% | ||
| Interest Coverage | 9.3 | ||
| Cash Conversion | 72.84% | ||
| Profit Quality | 143.51% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.91 |
F-Score6
WACC5.67%
ROIC/WACC2.23
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
EPS Next Y46.87%
EPS Next 2Y27.18%
EPS Next 3Y21.46%
EPS Next 5Y16.78%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
Revenue Next Year5.02%
Revenue Next 2Y6.25%
Revenue Next 3Y6.66%
Revenue Next 5Y7.08%
EBIT growth 1Y5.27%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year27.63%
EBIT Next 3Y14.66%
EBIT Next 5Y12.28%
FCF growth 1Y268.5%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y140.59%
OCF growth 3Y9.24%
OCF growth 5Y6.9%
COLOPLAST-B / CBHD.DE FAQ
What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE.
What is the valuation status for CBHD stock?
ChartMill assigns a valuation rating of 5 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for CBHD stock?
The financial health rating of COLOPLAST-B (CBHD.DE) is 5 / 10.
What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?
The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 46.87% in the next year.